Atrial Fibrillation, Embolism and Hemorrhage

PO-06-187 PULMONARY HEMORRHAGE DURING CRYOABLATION FOR ATRIAL FIBRILLATION: AN UNUSUAL COMPLICATION

HeartRhythm

APRIL 30, 2024

Cryoablation for atrial fibrillation is a widely used technique for pulmonary vein isolation. Known complications associated with cryoablation include tamponade, phrenic nerve injury, stroke, pulmonary embolism, pulmonary vein stenosis, and atrioesophageal fistulas.

Atrial Fibrillation

Atrial Fibrillation Pulmonary Hemorrhage Embolism

Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research

Stroke Journal

DECEMBER 21, 2023

Nonvalvular atrial fibrillation is a common rhythm disorder of middle-aged to older adults that can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants reduces the risk of these ischemic events but increases the risk of major and clinically relevant hemorrhages.

Atrial Fibrillation

Atrial Fibrillation Research Stroke Strokes

Use of Direct?Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundThere are limited data on the efficacy and safety of direct oral anticoagulants (DOACs) in patients with atrial fibrillation with significant tricuspid regurgitation (TR), which can lead to hepatic dysfunction and intestinal malabsorption. 1.36];P=0.79) and major bleeding (aHR, 0.78 [95% CI, 0.57–1.06];P=0.11). 1.06];P=0.11).

Atrial Fibrillation

Atrial Fibrillation Tricuspid Embolism Hemorrhage

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta?Analysis of Randomized Controlled Trials

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundAlthough older patients with atrial fibrillation are at heightened risk of thromboembolic and bleeding events, their optimal treatment choice remains uncertain.Methods and ResultsThis meta‐analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. prospero/.

Atrial Fibrillation

Atrial Fibrillation Embolism Stroke Strokes

Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients on Oral Anticoagulants: A Prognostic Meta‐Analysis

Journal of Cardiovascular Electrophysiology

DECEMBER 23, 2024

ABSTRACT Background Anemia is frequently observed as a comorbidity in atrial fibrillation (AF), especially in elderly patients and in those on anticoagulation. with 95% CI [1.59, 2.13], p <0.01), a 32% increase in the risk of intracranial hemorrhage (HR: 1.32 This has been associated with poor clinical outcomes.

Atrial Fibrillation

Atrial Fibrillation Outcomes Embolism Hemorrhage

Abstract TP13: Effectiveness and safety of direct oral anticoagulation vs. warfarin for primary prevention of stroke and bleeding risk among patients with atrial fibrillation.

Stroke Journal

JANUARY 30, 2025

Pooled analysis of primary and secondary endpoints showed that DOAC significantly reduced the risk of stroke or systemic embolism by 18% (OR, 0.82(95%CI: 0.97), P=0.02), and hemorrhagic stroke by 57% (OR, 0.43(95%CI: 0.91), P<0.01), stroke by 19% (OR, 0.81(95%CI: 0.56), P<0.01) when compared with warfarin.

Atrial Fibrillation

Atrial Fibrillation Stroke Strokes Embolism

InterAtrial Block

EMS 12-Lead

AUGUST 25, 2024

MRI Brain demonstrated Left MCA acute/subacute infarct, MCA/PCA watershed, and no hemorrhagic transformation. And since common things are common, the statistical probability favors Atrial Fibrillation (AFib) as the culprit. Here is the admission ECG. We do have the ECG. But the ECG is Sinus! AFib can come and go.

AFIB

AFIB Atrial Fibrillation Embolism RN

Abstract 66: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: Primary Results of the START Trial

Stroke Journal

FEBRUARY 1, 2024

Introduction:Clinical practice guidelines recommend initiation of anticoagulation within 2 weeks after stroke due to atrial fibrillation (AF). The primary outcome was an ischemic (stroke or systemic embolus) or hemorrhagic (ICH or major systemic hemorrhage) event observed within 30 days from the index stroke time of onset.

Atrial Fibrillation

Atrial Fibrillation Stroke Strokes Hemorrhage

Abstract WP23: Hemorrhagic Transformation Following Anticoagulation in Victims of Acute Ischemic Stroke Secondary to Intra-Cardiac Thrombi

Stroke Journal

FEBRUARY 1, 2024

Although there have been multiple studies investigating the safe timing of anticoagulation initiation following AIS in patients with atrial fibrillation, the results varied.

Hemorrhage

Hemorrhage Stroke Strokes Atrial Fibrillation

Abstract 018: External carotid artery Pseudo aneurysm induced Internal Carotid Artery compression causing acute ischemic stroke

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Eventually, the PSA of the Internal maxillary artery (IMAX) was embolized, resulting in resolution of the patient's symptoms.MethodsCase ReportResultsA 75‐year‐old male with a history of atrial fibrillation on Eliquis presented to the emergency department after sustaining a gunshot wound to the left face.

Aneurysm

Aneurysm Stroke Strokes Embolism

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation

Circulation

JANUARY 24, 2024

The primary efficacy and safety outcomes were stroke or systemic embolic events (stroke/SEE) and major bleeding, respectively; secondary outcomes were ischemic stroke/SEE, intracranial hemorrhage, death, and the net clinical outcome (stroke/SEE, major bleeding, or death). Each outcome was examined across BMI and BW.

Atrial Fibrillation

Atrial Fibrillation BMI Stroke Strokes

Abstract 4141940: Outcomes in Middle Eastern Atrial Fibrillation Patients with Prior Ischemic Stroke/Systemic Embolism: Findings from the JoFib Study

Circulation

NOVEMBER 11, 2024

Patients with a history of prior hemorrhagic stroke were excluded from this analysis. Circulation, Volume 150, Issue Suppl_1 , Page A4141940-A4141940, November 12, 2024.

Atrial Fibrillation

Atrial Fibrillation Embolism Stroke Strokes

Abstract 145: New Oral Anticoagulant Therapy Versus Warfarin In Patients With Atrial Fibrillation And Previous Stroke or Transient Ischemic Attack. An Updated Meta-analysis.

Stroke Journal

JANUARY 30, 2025

Background:Patients with atrial fibrillation (AF) and previous stroke or transient ischemic attack (TIA) are at high risk of recurrent stroke. Heterogeneity was examined using I2statistics.Results:We included 7 RCTs and 2 non-RCTs comparing NOAC to warfarin in patients with atrial fibrillation and previous stroke or TIA.

Atrial Fibrillation

Atrial Fibrillation Stroke Strokes Hemorrhage

Abstract TMP78: Disparities in Experiencing Major Adverse Cardiovascular Events Among Survivors of Spontaneous Intracerebral Hemorrhage by Hematoma Location

Stroke Journal

FEBRUARY 1, 2024

Patients with atrial fibrillation had a higher risk of AIS (1.47, 1.18 - 1.84) and MACE (1.26, 1.07 - 1.49). Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% lobar ICH), 3.3%, 3.1%, 0.5%, and 8.1%, respectively, experienced r-ICH, AIS, AMI, and MACE.

Hemorrhage

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

DAIC

JANUARY 22, 2024

Kown, Asan Medical Center, Seoul, Korea Golden Bridge II Effect of an Artificial Intelligence-Based Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients With Acute Ischemic Stroke : A Cluster-Randomized Clinical Trial: Zixiao Li, Beijing Tiantan Hospital, Capital Medical University, Beijing, China Friday, Feb.

Stroke

Stroke Strokes Hospital Stents

Emergency Department Syncope Workup: After H and P, ECG is the Only Test Required for Every Patient.

Dr. Smith's ECG Blog

APRIL 8, 2015

Also consider non-hemorrhagic volume depletion, dehydration : orthostatic vitals may uncover this [see Mendu et al. (3)]. Serious outcomes included death, arrhythmia, myocardial infarction, structural heart disease, pulmonary embolism, and hemorrhage. Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade.

Arrhythmia

Arrhythmia Outcomes Chest Pain Risk Factors

Cardiovascular Update

PO-06-187 PULMONARY HEMORRHAGE DURING CRYOABLATION FOR ATRIAL FIBRILLATION: AN UNUSUAL COMPLICATION

Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research

Use of Direct?Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation

Webinars

Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta?Analysis of Randomized Controlled Trials

Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients on Oral Anticoagulants: A Prognostic Meta‐Analysis

Abstract TP13: Effectiveness and safety of direct oral anticoagulation vs. warfarin for primary prevention of stroke and bleeding risk among patients with atrial fibrillation.

InterAtrial Block

Abstract 66: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: Primary Results of the START Trial

Abstract WP23: Hemorrhagic Transformation Following Anticoagulation in Victims of Acute Ischemic Stroke Secondary to Intra-Cardiac Thrombi

Abstract 018: External carotid artery Pseudo aneurysm induced Internal Carotid Artery compression causing acute ischemic stroke

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation

Abstract 4141940: Outcomes in Middle Eastern Atrial Fibrillation Patients with Prior Ischemic Stroke/Systemic Embolism: Findings from the JoFib Study

Abstract 145: New Oral Anticoagulant Therapy Versus Warfarin In Patients With Atrial Fibrillation And Previous Stroke or Transient Ischemic Attack. An Updated Meta-analysis.

Abstract TMP78: Disparities in Experiencing Major Adverse Cardiovascular Events Among Survivors of Spontaneous Intracerebral Hemorrhage by Hematoma Location

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

Emergency Department Syncope Workup: After H and P, ECG is the Only Test Required for Every Patient.

Stay Connected